结核病指数病例的密切接触者队列中的最小免疫细胞子集差异
Sudhasini Panda1, Catherine Cheng1, Naomi Hillery2
1Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.
bioRxiv : the preprint server for biology
|August 13, 2025
概括
免疫分析很难区分结核病 (TB) 感染阶段在密切接触,仅基于QuantiFERON-TB Gold (QFT) 测试结果. 活跃的结核病患者表现出明显的免疫变化,与具有不同QFT轨迹的接触者不同.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 结核病研究 结核病研究
背景情况:
- 了解结核病 (TB) 感染谱中的免疫反应扰乱至关重要.
- 系列QuantiFERON-TB Gold (QFT) 测试跟踪结核病接触者的免疫状态,但免疫分层仍然不清楚.
研究的目的:
- 为了研究不同QFT测试轨迹的个体之间的免疫学差异.
- 评估ex vivo免疫表型化在区分结核病感染阶段的有用性.
主要方法:
- 随着一组肺结核患者的密切接触者进行了连续QFT测试.
- 分层联系到QFT增长型,QFT转换型,QFT+稳定型和QFT-子组.
- 执行了ex vivo免疫表型,包括细胞频率,激活标记,T辅助子集和抗原特异性反应 (AIM测定).
主要成果:
- 在QFT亚组中观察到最小的免疫细胞差异,仅通过QFT动态来表明有限的分层.
- 与QFT接触者相比,QFT+患者的抗原特异性CD4 T细胞反应更高.
- 活跃的结核病患者表现出显著的免疫干扰,包括高抗原特异性T细胞和激活的免疫细胞,这些细胞随着治疗而减少.
结论:
- 活体免疫分析 (ex vivo immune profiling) 强有力的区分了活性结核病与非疾病状态,但缺乏QFT子组的解决方案.
- 基于血液的免疫分析可能无法捕捉结核病接触者的微妙免疫变化.
- 在结核病接触者中,免疫学上区分QFT定义的子组仍然存在挑战.
更多相关视频
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
2.4K
06:13Enzyme-linked Immunospot Assay ELISPOT: Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens
Published on: November 23, 2010
35.0K
相关概念视频
Pulmonary Tuberculosis I
324
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
324
Pulmonary Tuberculosis III
443
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
443
Pulmonary Tuberculosis IV
204
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
204
Pulmonary Tuberculosis II
346
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
346
Pulmonary Tuberculosis V
239
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
239
